India Launches HPV Vaccination Drive for Girls to Combat Cervical Cancer

HPV Vaccination Campaign Begins in Rajasthan

The HPV vaccination initiative for girls aged 14 is set to commence on February 28 in Ajmer, Rajasthan, with Prime Minister Narendra Modi spearheading the effort to eradicate preventable cancers among women. The campaign will utilize the single-dose Gardasil 4 vaccine, which protects against HPV types 16 and 18, known to cause cervical cancer, as well as types 6 and 11. An official communication will be dispatched to all states on February 25, as stated by the Union Health Ministry. The letter from Aradhana Patnaik, Additional Secretary and Mission Director (NHM), confirmed the Prime Minister's participation in the launch from Ajmer. During this event, all states and Union territories will connect virtually, with chief ministers, administrators, and health ministers in attendance.

"Girls aged 14 nationwide will receive the Gardasil 4 vaccine at Government Health facilities, including Ayushman Arogya Mandir-Primary Health Centers, Community Health Centers, sub-district/district hospitals, and government medical colleges and hospitals," the letter further explained. Cervical cancer is one of the most prevalent cancers among women in India, with the country accounting for a significant portion of global cases, leading to thousands of new diagnoses annually. Health professionals assert that extensive HPV vaccination is a highly effective strategy to alleviate this health burden.

Understanding HPV and Its Risks

What is HPV, and why is it dangerous?

HPV, or Human Papillomavirus, is a widespread viral infection primarily spread through skin-to-skin contact, including sexual activity. While many HPV infections resolve independently, certain high-risk strains, particularly HPV types 16 and 18, account for nearly 70% of cervical cancer cases globally. Persistent infections with these high-risk types can lead to abnormal cervical cell changes, which may progress to cervical cancer if not detected and treated promptly. Therefore, vaccination against HPV and regular cervical screenings are essential preventive measures.

Details on Gardasil 4 and Its Protective Benefits

All about Gardasil 4 and how it protects

Gardasil 4 is a crucial vaccine in the fight against HPV. This quadrivalent vaccine offers protection against four HPV types:

• HPV 6
• HPV 11
• HPV 16
• HPV 18

Experts highlight that HPV 16 and 18 are high-risk strains linked to cervical cancer, while HPV 6 and 11 are associated with genital warts. By targeting these four strains, Gardasil 4 significantly reduces the risk of HPV-related diseases. The vaccine prompts the immune system to produce antibodies against these HPV types, enabling the body to recognize and neutralize the virus if exposed later. Important guidelines for Gardasil 4 include:

• Complete all doses for optimal effectiveness.
• Stay hydrated by drinking plenty of water.
• Contact your doctor if you experience mild symptoms like fever or rash.
• Postpone vaccination if you are unwell.
• Avoid alcohol a day or two before receiving the vaccine.

Who Should Receive the HPV Vaccine?

Who should take the HPV vaccine?

Health authorities recommend the HPV vaccine for:

• Girls and boys aged 9 to 14 years
• Adolescents and young adults who have not been vaccinated previously
• Individuals who may be exposed to HPV for maximum effectiveness

The vaccine is generally administered in two or three doses, depending on the age at which vaccination begins. Experts stress that the vaccine is preventive and does not treat existing HPV infections or cervical cancer. However, widespread vaccination can significantly reduce future cases of cervical cancer.